MetaBiom
Microbiome & Chronic Diseases

Evidence Based Medicine
Sign in

Heart failure {40000230}

Record Keys


Definition:
Heart failure
Class:[  ]

Details


Other Terms:
HF
Initialisation date:[  ]

Meta Information


ICD:[  ]
Category:[  ]
MedDra ID:
10019285
MedDra Level:
llt

Notes


[  ]

Shared Notes


[  ]


[Coverage other Diseases (Overlap > 0.25)]

DiseaseOverlapCommon increased OrganismCommon decreased Organism
Heart failure 1.0000 10 (100%) : Anaerostipes | Campylobacter | Coprobacillus | Dysgonomonas | Enterococcus | Erysipelatoclostridium | Fusobacterium | Lactobacillus | Streptococcus | Veillonella 14 (100%) : Bilophila | Burkholderia | Butyricicoccus | Clostridium | Collinsella | Dorea | Dorea longicatena | Eubacterium rectale | Faecalibacterium prausnitzii | Intestinimonas | Johnsonella | Mycobacterium | Oscillibacter | Parasutterella
Crohn's disease 0.5857 6 (60%) : Anaerostipes | Enterococcus | Fusobacterium | Lactobacillus | Streptococcus | Veillonella 8 (57%) : Bilophila | Clostridium | Collinsella | Dorea | Eubacterium rectale | Faecalibacterium prausnitzii | Mycobacterium | Oscillibacter
Colorectal cancer 0.5500 6 (60%) : Campylobacter | Coprobacillus | Enterococcus | Fusobacterium | Lactobacillus | Streptococcus 7 (50%) : Collinsella | Dorea | Eubacterium rectale | Faecalibacterium prausnitzii | Intestinimonas | Oscillibacter | Parasutterella
Ulcerative Colitis 0.4571 7 (70%) : Anaerostipes | Coprobacillus | Enterococcus | Erysipelatoclostridium | Lactobacillus | Streptococcus | Veillonella 3 (21%) : Bilophila | Eubacterium rectale | Faecalibacterium prausnitzii
Chronic kidney disease 0.4500 4 (40%) : Coprobacillus | Erysipelatoclostridium | Lactobacillus | Streptococcus 7 (50%) : Butyricicoccus | Clostridium | Collinsella | Dorea | Eubacterium rectale | Faecalibacterium prausnitzii | Parasutterella
HIV infection 0.4286 5 (50%) : Campylobacter | Fusobacterium | Lactobacillus | Streptococcus | Veillonella 5 (36%) : Bilophila | Clostridium | Collinsella | Dorea | Parasutterella
Non-alcoholic fatty liver disease 0.4143 4 (40%) : Enterococcus | Lactobacillus | Streptococcus | Veillonella 6 (43%) : Bilophila | Clostridium | Dorea | Faecalibacterium prausnitzii | Oscillibacter | Parasutterella
Type 2 diabetes 0.3786 4 (40%) : Enterococcus | Fusobacterium | Lactobacillus | Streptococcus 5 (36%) : Bilophila | Collinsella | Dorea | Eubacterium rectale | Faecalibacterium prausnitzii
Parkinson's Disease 0.3786 4 (40%) : Enterococcus | Lactobacillus | Streptococcus | Veillonella 5 (36%) : Clostridium | Collinsella | Dorea | Dorea longicatena | Faecalibacterium prausnitzii
Primary sclerosing cholangitis-IBD 0.3714 6 (60%) : Coprobacillus | Enterococcus | Fusobacterium | Lactobacillus | Streptococcus | Veillonella 2 (14%) : Dorea | Faecalibacterium prausnitzii
Cirrhosis 0.3571 5 (50%) : Enterococcus | Fusobacterium | Lactobacillus | Streptococcus | Veillonella 3 (21%) : Dorea | Eubacterium rectale | Faecalibacterium prausnitzii
Chronic Obstructive Pulmonary Disease 0.3357 6 (60%) : Campylobacter | Dysgonomonas | Fusobacterium | Lactobacillus | Streptococcus | Veillonella 1 (7%) : Clostridium
Hepatocellular cancer 0.3357 6 (60%) : Anaerostipes | Campylobacter | Enterococcus | Fusobacterium | Streptococcus | Veillonella 1 (7%) : Collinsella
Multiple Sclerosis 0.3286 3 (30%) : Coprobacillus | Lactobacillus | Streptococcus 5 (36%) : Butyricicoccus | Clostridium | Dorea | Eubacterium rectale | Faecalibacterium prausnitzii
Autism 0.3286 3 (30%) : Enterococcus | Lactobacillus | Streptococcus 5 (36%) : Bilophila | Butyricicoccus | Collinsella | Eubacterium rectale | Faecalibacterium prausnitzii
Rheumatoid Arthritis 0.3214 5 (50%) : Campylobacter | Fusobacterium | Lactobacillus | Streptococcus | Veillonella 2 (14%) : Collinsella | Eubacterium rectale
Short Bowel Syndrome 0.3214 5 (50%) : Enterococcus | Fusobacterium | Lactobacillus | Streptococcus | Veillonella 2 (14%) : Collinsella | Dorea
Irritable bowel syndrome 0.3071 4 (40%) : Enterococcus | Lactobacillus | Streptococcus | Veillonella 3 (21%) : Butyricicoccus | Dorea | Oscillibacter
Hypertension 0.2929 3 (30%) : Fusobacterium | Lactobacillus | Streptococcus 4 (29%) : Clostridium | Dorea | Eubacterium rectale | Oscillibacter
Pancreatic Cancer 0.2929 3 (30%) : Campylobacter | Lactobacillus | Veillonella 4 (29%) : Bilophila | Butyricicoccus | Dorea | Parasutterella
Primary sclerosing cholangitis 0.2857 5 (50%) : Enterococcus | Fusobacterium | Lactobacillus | Streptococcus | Veillonella 1 (7%) : Faecalibacterium prausnitzii
Alcoholism 0.2714 4 (40%) : Enterococcus | Lactobacillus | Streptococcus | Veillonella 2 (14%) : Collinsella | Dorea
Covid-19 0.2714 4 (40%) : Coprobacillus | Erysipelatoclostridium | Streptococcus | Veillonella 2 (14%) : Eubacterium rectale | Faecalibacterium prausnitzii
Obesity 0.2571 3 (30%) : Campylobacter | Fusobacterium | Lactobacillus 3 (21%) : Faecalibacterium prausnitzii | Intestinimonas | Oscillibacter
Cystic fibrosis 0.2571 3 (30%) : Enterococcus | Streptococcus | Veillonella 3 (21%) : Dorea longicatena | Eubacterium rectale | Faecalibacterium prausnitzii

[Coverage Factors (Overlap > 0.10)]

FactorOverlapCommon increased OrganismCommon decreased Organism
Exposure to Glyphosate 0.1357 2 (20%) : Fusobacterium | Veillonella 1 (7%) : Butyricicoccus